Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre,... by Yang, Yunpeng, Prof, Qu, Song, Prof, Li, Jingao, Prof, Hu, Chaosu, Prof, Xu, Mingjun, Prof, Li, Weidong, Prof, Zhou, Ting, MD, Shen, Liangfang, Prof, Wu, Hui, Prof, Lang, Jinyi, Prof, Hu, Guangyuan, Prof, Luo, Zhanxiong, Prof, Fu, Zhichao, Prof, Qu, Shenhong, Prof, Feng, Weineng, Prof, Chen, Xiaozhong, Prof, Lin, Shaojun, Prof, Zhang, Weimin, Prof, Li, Xiaojiang, Prof, Sun, Yan, Prof, Lin, Zhixiong, Prof, Lin, Qin, Prof, Lei, Feng, Prof, Long, Jianting, Prof, Hong, Jinsheng, Prof, Huang, Xiaoming, Prof, Zeng, Lingzhi, Prof, Wang, Peiguo, Prof, He, Xiaohui, Prof, Zhang, Ben, MS, Yang, Qing, MD, Zhang, Xiaojing, MD, Zou, Jianjun, MD, Fang, Wenfeng, Prof, Zhang, Li, Prof

Get full text